Bach Pharma, Inc. Logo
  • GVT
    • How GVT Works
    • Oxidative Stress & GVT
  • Science & Research
    • Current Research
  • Investing
    • Investment Opportunities
  • Who We Help
    • GWI – Gulf War Illness
    • ALS – Lou Gherig’s Disease
    • Other Diseases
  • Veterans
  • Communications
    • Press Releases
    • Corporate Communications & Updates
  • About Us
    • Management
    • Directors
    • Advisors
    • Collaborators
  • Contact Us
  • Menu

Press Releases

Texas A&M - Monosodium Luminol Shows Promise for Treating Gulf War Illness
January 17, 2020

Bach Pharma 2019 GVT Press Release
August 16, 2019

Department of Defense Report Shows Bach Pharma Drug GVT Reverses Brain Dysfunction
August 1, 2017

Bach Pharma, Inc. Announces Appointment of Dr. Pravin Chaturvedi to Board of Directors
August 3, 2016

Bach Pharma, Inc. Appoints Kelly Blackburn as Chief Executive Officer
July 5, 2016

Possible Hope for Veterans Suffering From Gulf War Illness
January 30, 2016

Bach Pharma, Inc. Appoints William S. Lynn, M.D. as Lifetime Director Emeritus
February 10, 2013

Bach Pharma, Inc. Appoints Mr. Daniel Cato as President
February 1, 2013

The Foundation for the N.I.H. Launches First U.S./Russia Scientific Forum Planning Meeting to Advance Research Collaborations
April 20, 2011

Bach Pharma Announces Preventive Drug Development Program
January 4, 2010

logo

 © 2025 Bach Pharma, Inc., (BACH)
BIG STUDIO.NET web design Plymouth